Fabrication and Evaluation of Hyaluronic Acid-Coated Albumin Nanoparticles for Delivery of Gemcitabine
The present work demonstrated that HA-Gem-BSANPs could be a potential strategy to improve Gem's therapeutic efficacy by selectively targeting the tumor site.
Authors
- Saleem Akbar (ORCID: https://orcid.org/0000-0001-5661-371X)
- Aman Kumar Mahto
- S.L. Neha
- Laxmi Rani (ORCID: https://orcid.org/0000-0003-1341-6876)
- Rikeshwer Prasad Dewangan (ORCID: https://orcid.org/0000-0001-5537-6919)
- Juhi Verma
- Prabhat Kumar Sahoo (ORCID: https://orcid.org/0000-0003-2220-9617)
- Vikas Jain (ORCID: https://orcid.org/0000-0001-5863-3159)
- Shweta Paroha
- Ravindra Dhar Dubey
- Ashwini Kumar Mishra (ORCID: https://orcid.org/0000-0003-3279-6851)
Institutions
- Jamia Hamdard (IN)
- Lupin Pharmaceuticals (India) (IN)
- Delhi Pharmaceutical Science and Research University (IN)
- National Institute of Immunology (IN)
Publication Details
- Journal
- Current Drug Delivery
- Published
- 2025-02-13
- DOI
- https://doi.org/10.2174/0115672018317615240926163652
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00